« Back to Research Deepdives

The Effects of Genetically Higher Blood Levels of Polyunsaturated Fats on Heart Disease

This content is restricted to members.

To view our premium content, sign up for a membership:


Register New Account

Choose your membership level

Choose Your Payment Method

‹ Back to Research Deepdives


1.Li J, Guasch-Ferré M, Li Y, Hu FB. Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr. 2020 Jul 1;112(1):150–67.
2.Farvid MS. Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Circulation. 2015;130(18):1568–78.
3.Marklund M, Wu JHY, Imamura F, del Gobbo LC, Fretts A, de Goede J, et al. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019 May 21;139(21):2422–36.
4.Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3).
5.Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews. 2020 May 19;5(5):CD011737.
6.Keys A, Anderson JT, Grande F. Prediction of Serum-Cholesterol Responses of Man to Changes in Fat in the Diet. The Lancet. 1957;Nov 16(73(7003)):959-966.
7.Hegsted MD, Ausman LM, Johnson JA, Dallal GE. Fat and Serum Lipids: Am J Clin Nutr. 1993;57(6):875–83.
8.Clarke R, Frost C, Collins R, Appleby PN, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ. 1997;314:112–7.
9.Ruscica M, Sirtori CR, Carugo S, Calder PC, Corsini A. Omega-3 and cardiovascular prevention – Is this still a choice? Pharmacol Res. 2022 Aug;182:106342.
10.Farukhi ZM, Mora S, Manson JE. Marine Omega-3 Fatty Acids and Cardiovascular Disease Prevention: Seeking Clearer Water. Mayo Clin Proc. 2021 Feb;96(2):277–9.
11.Toth PP, Chapman MJ, Parhofer KG, Nelson JR. Differentiating EPA from EPA/DHA in cardiovascular risk reduction. American Heart Journal Plus: Cardiology Research and Practice. 2022 May;17:100148.
12.Sheppard JP, Lakshmanan S, Dahal S, Roy SK, Bhatt DL, Budoff MJ, et al. EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis. JACC Cardiovasc Imaging. 2022 Oct;15(10):1825–8.
13.Arab L, Akbar J. Biomarkers and the measurement of fatty acids. Public Health Nutr. 2002 Dec 22;5(6a):865–71.
14.Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clin Biochem. 2010 Feb;43(3):338–40.
15.Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013 Feb 4;346(feb04 3):e8707–e8707.
16.Calder PC, Ahluwalia N, Albers R, Bosco N, Bourdet-Sicard R, Haller D, et al. A Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies. British Journal of Nutrition. 2013 Jan 23;109(S1):S1–34.
17.Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: A systematic review. Nutr Metab (Lond). 2011;8:1–15.
18.Johnson GH, Fritsche K. Effect of Dietary Linoleic Acid on Markers of Inflammation in Healthy Persons: A Systematic Review of Randomized Controlled Trials. J Acad Nutr Diet. 2012;112(7):1029-1041.e15
19.Bradbury J. Docosahexaenoic acid (DHA): An ancient nutrient for the modern human brain. Nutrients. 2011;3(5):529–54.
20.Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer’s disease: Can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids. 2013;88(1):61–70.
21.Hu Y, Hu FB, Manson JAE. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants. J Am Heart Assoc. 2019;8(19):e013543.
22.Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. The Lancet. 2003 Feb;361(9356):477–85.
23.Cawood AL, Ding R, Napper FL, Young RH, Williams JA, Ward MJA, et al. Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis. 2010 Sep;212(1):252–9.
24.Yuhas R, Pramuk K, Lien EL. Human milk fatty acid composition from nine countries varies most in DHA. Lipids. 2006 Sep;41(9):851–8.